Pharmacology Flashcards
What is the mechanism of action of the sulfonylureas?
Act by displacing the binding of ADP-Mg2+ from the SUR1 subunit (thus closing the KATP channel and stimulating insulin release)
Why would sulfonylureas not work in type 1 diabetes?
They increase insulin release from beta cells, in type 1 diabetes there are no functioning beta cells.
Examples of sulfonylureas?
tolbutamide, gliclazide, glibenclamide, glipizide
Tolbutamide, gliclazide, glibenclamide, glipizide are all examples of…
Sulfonylureas
What drugs for T2DM can cause hypos?
Sulfonylureas, Glinides (less likely than SUs),
Hypoglycaemia by excessive insulin secretion is a side effect of the sulfonylureas, who is more at risk of this side effect?
long acting agents (e.g. glibenclamide)
the elderly
patients with reduced hepatic/renal function, particularly chronic kidney disease (CKD)
Explain how the sulfonyureas can cause weight gain?
anabolic effect of insulin increased
appetite increased
urinary loss of glucose decreased
When are the sulfonyureas used?
first-line in patients intolerant of metformin, or with weight loss
second-line in conjunction with metformin
third line in conjunction with metformin and thiazolidinediones, or other drugs
Mechanism of action of the glinides?
Almost the same as sulfonylureas but binding is slightly different
Examples of the glinides?
Repaglinide and nateglinide
Repaglinide is subject to mainly hepatic metabolism – thus safer than SUs in ______
chronic kidney disease
Describe the incretin response, what two drugs for type 2 diabetes target this?
• Ingestion of food stimulates release of GLP-1 and IP from enteroendocrine cells in the small intestine (L cells in the ileum and K cells in the duodenum, respectively
• These enter the portal blood enhancing insulin release
• GLP-1 also decrease glucagon release
Hence blood glucose is decreased
The DPP-4 inhibitors and the incretin analogues
Describe the mechanism of action of the DPP-4 inhibitors
• The incretin response is reduced in type 2 so this drug tries to restore it pharmacology
• Action of GLP 1 and GIP are very rapidly terminated by the enzyme DPP 4
The Gliptins competitively inhibit DPP-4 prolonging the actions of endogenous GLP-1 and GIP and increasing plasma insulin
Repaglinide and nateglinide and examples of?
Glinides
Why are drugs that target the incretin response only helpful in type 2 diabetes?
They target a response which helps with insulin secretion, if no insulin secretion in the first place this is not helpful.
Examples of Gliptins/ DPP-4 inhibitors?
sitagliptin, saxagliptin, vildagliptin, linagliptin and alogliptin
Sitagliptin, saxagliptin, vildagliptin, linagliptin and alogliptin are all examples of?
Gliptins/ DPP-4 inhibitors